首页> 外文OA文献 >Evaluation of tumour microenvironment identifies immune correlates of response to combination immunotherapy with margetuximab (M) and pembrolizumab (P) in HER2+ gastroesophageal adenocarcinoma (GEA)

【2h】

Evaluation of tumour microenvironment identifies immune correlates of response to combination immunotherapy with margetuximab (M) and pembrolizumab (P) in HER2+ gastroesophageal adenocarcinoma (GEA)

机译：肿瘤微环境的评估鉴定了对Her2 +胃食管腺癌（GEA）中Margetuximab（M）和Pembrolizumab（P）对组合免疫疗法的免疫相关性的免疫相关性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
S. Rutella; S.E. Church; J. Vadakekolathu; S. Reeder; A.H. Sullivan; S. Warren; J. Baughman; J. Muth; H. Park; H. Uronis; Y.-K. Kang; M.C.H. Ng; P. Enzinger; K.W. Lee; K. Huber; A. Wynter-Horton; D. Li; Y.-J. Bang; J. Davidson-Moncada; D.V. Catenacci;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumab [J] . Fukuokaya Wataru, Kimura Takahiro, Yanagisawa Takafumi, BJU international . 2021,第1期

机译：用PEMBROLIZUMAB处理术治疗术治疗尿路上皮癌患者捕获治疗响应的实体肿瘤（IRECIST）的比较
2. Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study [J] . Bang Yung-Jue, Kang Yoon-Koo, Catenacci Daniel V., Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association . 2019,第4期

机译：单独或与化学疗法组合的Pembrolizumab为先进的胃或胃食管结合腺癌患者的一线治疗：II期非andomized keynote-059研究的结果
3. Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma [J] . Changhee Park, Kwon Joong Na, Hongyoon Choi, Theranostics . 2020,第23期

机译：肿瘤免疫谱通过FDG PET估计，具有深入学习与肺腺癌中的免疫疗法反应相关
4. Pooling Functional Genetic Screens to Identify Genetic Correlates of Tumor Immunotherapy Response [D] . Chang, Allison E. B. 2019

机译：汇集功能性遗传筛查以鉴定肿瘤免疫疗法反应的遗传相关性
5. Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses [O] . Yu-Pei Chen, Jia-Wei Lv, Yan-Ping Mao, 2021

机译：揭开鼻咽癌中的肿瘤微环境异质性鉴定了预测预后和免疫疗法反应的生物学截然不同的免疫亚型
6. MAHOGANY: margetuximab combination in HER2+ unresectable/metastatic gastric/gastroesophageal junction adenocarcinoma [O] . Daniel VT Catenacci, Minori Rosales, Hyun Cheol Chung, 2021

机译：桃花心木：Margetuximab在HER2 +不可切除/转移性胃/胃食管啮合结合腺癌结合

Evaluation of tumour microenvironment identifies immune correlates of response to combination immunotherapy with margetuximab (M) and pembrolizumab (P) in HER2+ gastroesophageal adenocarcinoma (GEA)

著录项

引文网络

相似文献

相关主题

期刊订阅